Canadian Myeloma Research Group
3rd Annual CMRG Conference
October 23-24, 2026 | Park Hyatt Hotel Toronto
The 3rd Annual Canadian Myeloma Research Group (CMRG) Conference will bring together leading hematologists, oncologists, researchers, healthcare professionals, industry partners, and patient advocates from across Canada to advance collaboration in Multiple Myeloma research and care. Taking place on October 23–24, 2026, at the Park Hyatt Toronto, this two-day conference will feature expert-led scientific presentations, clinical research updates, panel discussions, and networking opportunities focused on the latest developments in multiple myeloma diagnosis, treatment, and patient outcomes.
Attendees will have the opportunity to:
- Learn about the latest advances in myeloma research and clinical trials.
- Hear from nationally recognized experts and thought leaders.
- Participate in interactive discussions on emerging therapies and standards of care.
- Network with healthcare professionals, researchers, industry representatives, and patient advocacy organizations.
- Explore collaborative opportunities that support innovation and improve outcomes for Canadians living with multiple myeloma.
Location
Park Hyatt Hotel Toronto
4 Avenue Rd, Toronto, ON
M5R 2E8
Friday, October 23rd, 2026
Day 1 - Friday, October 23, 2026
| Time | Description | Speaker |
|---|---|---|
| 07:00 – 08:00 | Canadian Myeloma Research Conference – Breakfast | |
| 08:00 – 08:05 | Welcome to the Canadian Myeloma Research Conference | Mr. Engin Gul |
| 08:05 – 08:30 | Advances in Myeloma Treatment, Access and Unmet Needs | Dr. Donna Reece |
| 08:30 – 08:45 | Evolving Utility of RWE & Updates on the CMRG Database | Dr. Richard LeBlanc |
| 08:45 – 09:15 | CMRG National Biobank Initiative – Opportunities in Advancing Basic Research | Dr. Chris Venner |
| 09:15 – 10:00 | KeynoteDesigning Relevant Academic Trials, Including Correlatives, in Myeloma | Dr. Charlotte Pawlyn |
| 10:00 – 10:15 | Refreshment Break – Ballroom Atrium Foyer | |
| 10:15 – 11:00 | KeynoteBuilding National Trials in Multiple Myeloma: The Greek Experience | Dr. Efstathios Kastritis |
| 11:00 – 11:15 | CMRG Academic Trials – Experiences and Challenges | Dr. Darrell White |
| 11:15 – 11:45 | PanelAcademic Trials – Opportunities, Challenges & Solutions | Invited Panel |
| 11:45 – 12:15 | CMRG Announcement | |
| 12:15 – 13:00 | Lunch – Ballroom Room | |
| 13:00 – 13:30 | Industry Meeting (Closed) | Johnson & Johnson |
| 13:30 – 14:00 | Industry Meeting (Closed) | GlaxoSmithKline |
| 14:00 – 14:20 | Industry Meeting (Closed) | AbbVie |
| 14:20 – 14:40 | Industry Meeting (Closed) | Bristol Myers Squibb |
| 14:40 – 15:00 | Industry Meeting (Closed) | Pfizer |
| 15:00 – 15:20 | Industry Meeting (Closed) | Regeneron |
| 15:20 – 15:40 | Industry Meeting (Closed) | Sanofi |
| 15:40 – 15:50 | Refreshment Break – Ballroom Atrium Foyer | |
| 15:50 – 16:30 | Highlights of the Day / Potential Steps Forward | TBD |
Day 2 - Saturday, October 24, 2026
| Time | Description | Speaker |
|---|---|---|
| 07:00 – 08:00 | Canadian Myeloma Research Conference – Breakfast | |
| 08:00 – 09:00 | CMRG Advisory Committee Breakout Meetings | Committee Chairs & Members |
| 09:00 – 09:30 | Clinical Trial Committee Report | Committee Chair |
| 09:30 – 10:00 | Sustainability Committee Report | Committee Chair |
| 10:00 – 10:30 | Translational Research and Biobank Committee Report | Committee Chair |
| 10:30 – 10:45 | Refreshment Break – Salon A | |
| 10:45 – 11:15 | Database Steering Committee Report | Committee Chair |
| 11:15 – 11:45 | Health Technology Evaluation Committee Report | Committee Chair |
| 11:45 – 12:15 | Discussion on Future Directions & Action Items | TBD |
| 12:15 – 12:20 | Closing Remarks | Dr. Darrell White |
Proudly Supported by Our 2026 Sponsors!
Platinum Sponsor
